nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Simvastatin—atherosclerosis	0.111	0.217	CbGbCtD
Tramadol—CYP2D6—Niacin—atherosclerosis	0.0676	0.133	CbGbCtD
Tramadol—CYP2D6—Simvastatin—atherosclerosis	0.0534	0.105	CbGbCtD
Tramadol—CYP2D6—Lovastatin—atherosclerosis	0.0523	0.103	CbGbCtD
Tramadol—CYP2D6—Pravastatin—atherosclerosis	0.0523	0.103	CbGbCtD
Tramadol—CYP3A4—Ezetimibe—atherosclerosis	0.0365	0.0717	CbGbCtD
Tramadol—CYP3A4—Rosuvastatin—atherosclerosis	0.0365	0.0717	CbGbCtD
Tramadol—CYP3A4—Simvastatin—atherosclerosis	0.034	0.0667	CbGbCtD
Tramadol—CYP3A4—Pravastatin—atherosclerosis	0.0332	0.0652	CbGbCtD
Tramadol—CYP3A4—Lovastatin—atherosclerosis	0.0332	0.0652	CbGbCtD
Tramadol—Dysgeusia—Simvastatin—atherosclerosis	0.000405	0.00111	CcSEcCtD
Tramadol—Flushing—Niacin—atherosclerosis	0.000405	0.00111	CcSEcCtD
Tramadol—Angioedema—Lovastatin—atherosclerosis	0.000404	0.00111	CcSEcCtD
Tramadol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000402	0.00111	CcSEcCtD
Tramadol—Anaemia—Ezetimibe—atherosclerosis	0.000401	0.0011	CcSEcCtD
Tramadol—Tinnitus—Pravastatin—atherosclerosis	0.0004	0.0011	CcSEcCtD
Tramadol—Malaise—Lovastatin—atherosclerosis	0.000399	0.0011	CcSEcCtD
Tramadol—Flushing—Pravastatin—atherosclerosis	0.000399	0.0011	CcSEcCtD
Tramadol—Cardiac disorder—Pravastatin—atherosclerosis	0.000399	0.0011	CcSEcCtD
Tramadol—Muscle spasms—Simvastatin—atherosclerosis	0.000398	0.00109	CcSEcCtD
Tramadol—Vertigo—Lovastatin—atherosclerosis	0.000397	0.00109	CcSEcCtD
Tramadol—Angioedema—Ezetimibe—atherosclerosis	0.000396	0.00109	CcSEcCtD
Tramadol—Angiopathy—Niacin—atherosclerosis	0.000396	0.00109	CcSEcCtD
Tramadol—Chills—Niacin—atherosclerosis	0.000391	0.00108	CcSEcCtD
Tramadol—Malaise—Ezetimibe—atherosclerosis	0.000391	0.00108	CcSEcCtD
Tramadol—Vision blurred—Simvastatin—atherosclerosis	0.00039	0.00107	CcSEcCtD
Tramadol—Arrhythmia—Niacin—atherosclerosis	0.00039	0.00107	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000388	0.00107	CcSEcCtD
Tramadol—Tremor—Simvastatin—atherosclerosis	0.000387	0.00107	CcSEcCtD
Tramadol—Chills—Pravastatin—atherosclerosis	0.000385	0.00106	CcSEcCtD
Tramadol—Insomnia—Rosuvastatin—atherosclerosis	0.000385	0.00106	CcSEcCtD
Tramadol—Ill-defined disorder—Simvastatin—atherosclerosis	0.000384	0.00106	CcSEcCtD
Tramadol—Arrhythmia—Pravastatin—atherosclerosis	0.000384	0.00106	CcSEcCtD
Tramadol—Palpitations—Ezetimibe—atherosclerosis	0.000383	0.00106	CcSEcCtD
Tramadol—Paraesthesia—Rosuvastatin—atherosclerosis	0.000382	0.00105	CcSEcCtD
Tramadol—Anaemia—Simvastatin—atherosclerosis	0.000382	0.00105	CcSEcCtD
Tramadol—Erythema—Niacin—atherosclerosis	0.00038	0.00105	CcSEcCtD
Tramadol—Malnutrition—Niacin—atherosclerosis	0.00038	0.00105	CcSEcCtD
Tramadol—Cough—Ezetimibe—atherosclerosis	0.000378	0.00104	CcSEcCtD
Tramadol—Angioedema—Simvastatin—atherosclerosis	0.000378	0.00104	CcSEcCtD
Tramadol—Chest pain—Lovastatin—atherosclerosis	0.000376	0.00104	CcSEcCtD
Tramadol—Arthralgia—Lovastatin—atherosclerosis	0.000376	0.00104	CcSEcCtD
Tramadol—Myalgia—Lovastatin—atherosclerosis	0.000376	0.00104	CcSEcCtD
Tramadol—Anxiety—Lovastatin—atherosclerosis	0.000375	0.00103	CcSEcCtD
Tramadol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000375	0.00103	CcSEcCtD
Tramadol—Hypertension—Ezetimibe—atherosclerosis	0.000374	0.00103	CcSEcCtD
Tramadol—Flatulence—Niacin—atherosclerosis	0.000374	0.00103	CcSEcCtD
Tramadol—Malaise—Simvastatin—atherosclerosis	0.000373	0.00103	CcSEcCtD
Tramadol—Tension—Niacin—atherosclerosis	0.000373	0.00103	CcSEcCtD
Tramadol—Discomfort—Lovastatin—atherosclerosis	0.000372	0.00102	CcSEcCtD
Tramadol—Vertigo—Simvastatin—atherosclerosis	0.000372	0.00102	CcSEcCtD
Tramadol—Arthralgia—Ezetimibe—atherosclerosis	0.000369	0.00102	CcSEcCtD
Tramadol—Chest pain—Ezetimibe—atherosclerosis	0.000369	0.00102	CcSEcCtD
Tramadol—Myalgia—Ezetimibe—atherosclerosis	0.000369	0.00102	CcSEcCtD
Tramadol—Nervousness—Niacin—atherosclerosis	0.000369	0.00102	CcSEcCtD
Tramadol—Flatulence—Pravastatin—atherosclerosis	0.000368	0.00101	CcSEcCtD
Tramadol—Dry mouth—Lovastatin—atherosclerosis	0.000368	0.00101	CcSEcCtD
Tramadol—Tension—Pravastatin—atherosclerosis	0.000367	0.00101	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000367	0.00101	CcSEcCtD
Tramadol—Dysgeusia—Pravastatin—atherosclerosis	0.000366	0.00101	CcSEcCtD
Tramadol—Muscle spasms—Niacin—atherosclerosis	0.000365	0.00101	CcSEcCtD
Tramadol—Discomfort—Ezetimibe—atherosclerosis	0.000365	0.001	CcSEcCtD
Tramadol—Constipation—Rosuvastatin—atherosclerosis	0.000364	0.001	CcSEcCtD
Tramadol—Pain—Rosuvastatin—atherosclerosis	0.000364	0.001	CcSEcCtD
Tramadol—Confusional state—Lovastatin—atherosclerosis	0.000364	0.001	CcSEcCtD
Tramadol—Nervousness—Pravastatin—atherosclerosis	0.000363	0.001	CcSEcCtD
Tramadol—Dry mouth—Ezetimibe—atherosclerosis	0.000361	0.000994	CcSEcCtD
Tramadol—Anaphylactic shock—Lovastatin—atherosclerosis	0.000361	0.000993	CcSEcCtD
Tramadol—Muscle spasms—Pravastatin—atherosclerosis	0.000359	0.00099	CcSEcCtD
Tramadol—Infection—Lovastatin—atherosclerosis	0.000359	0.000987	CcSEcCtD
Tramadol—Vision blurred—Niacin—atherosclerosis	0.000358	0.000985	CcSEcCtD
Tramadol—Confusional state—Ezetimibe—atherosclerosis	0.000357	0.000982	CcSEcCtD
Tramadol—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000354	0.000974	CcSEcCtD
Tramadol—Thrombocytopenia—Lovastatin—atherosclerosis	0.000353	0.000973	CcSEcCtD
Tramadol—Vision blurred—Pravastatin—atherosclerosis	0.000352	0.00097	CcSEcCtD
Tramadol—Arthralgia—Simvastatin—atherosclerosis	0.000352	0.000969	CcSEcCtD
Tramadol—Chest pain—Simvastatin—atherosclerosis	0.000352	0.000969	CcSEcCtD
Tramadol—Myalgia—Simvastatin—atherosclerosis	0.000352	0.000969	CcSEcCtD
Tramadol—Infection—Ezetimibe—atherosclerosis	0.000352	0.000968	CcSEcCtD
Tramadol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000351	0.000966	CcSEcCtD
Tramadol—Anxiety—Simvastatin—atherosclerosis	0.000351	0.000966	CcSEcCtD
Tramadol—Tremor—Pravastatin—atherosclerosis	0.00035	0.000964	CcSEcCtD
Tramadol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000348	0.000959	CcSEcCtD
Tramadol—Discomfort—Simvastatin—atherosclerosis	0.000348	0.000958	CcSEcCtD
Tramadol—Nervous system disorder—Ezetimibe—atherosclerosis	0.000347	0.000956	CcSEcCtD
Tramadol—Angioedema—Niacin—atherosclerosis	0.000347	0.000955	CcSEcCtD
Tramadol—Ill-defined disorder—Pravastatin—atherosclerosis	0.000347	0.000955	CcSEcCtD
Tramadol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000347	0.000954	CcSEcCtD
Tramadol—Anaemia—Pravastatin—atherosclerosis	0.000346	0.000951	CcSEcCtD
Tramadol—Anorexia—Lovastatin—atherosclerosis	0.000344	0.000947	CcSEcCtD
Tramadol—Skin disorder—Ezetimibe—atherosclerosis	0.000344	0.000946	CcSEcCtD
Tramadol—Angioedema—Pravastatin—atherosclerosis	0.000342	0.000941	CcSEcCtD
Tramadol—Vertigo—Niacin—atherosclerosis	0.000341	0.000939	CcSEcCtD
Tramadol—Syncope—Niacin—atherosclerosis	0.000341	0.000938	CcSEcCtD
Tramadol—Confusional state—Simvastatin—atherosclerosis	0.00034	0.000937	CcSEcCtD
Tramadol—Urticaria—Rosuvastatin—atherosclerosis	0.000338	0.000931	CcSEcCtD
Tramadol—Anaphylactic shock—Simvastatin—atherosclerosis	0.000338	0.000929	CcSEcCtD
Tramadol—Malaise—Pravastatin—atherosclerosis	0.000337	0.000928	CcSEcCtD
Tramadol—Abdominal pain—Rosuvastatin—atherosclerosis	0.000337	0.000927	CcSEcCtD
Tramadol—Vertigo—Pravastatin—atherosclerosis	0.000336	0.000925	CcSEcCtD
Tramadol—Palpitations—Niacin—atherosclerosis	0.000336	0.000924	CcSEcCtD
Tramadol—Infection—Simvastatin—atherosclerosis	0.000335	0.000923	CcSEcCtD
Tramadol—Loss of consciousness—Niacin—atherosclerosis	0.000334	0.000919	CcSEcCtD
Tramadol—Cough—Niacin—atherosclerosis	0.000331	0.000912	CcSEcCtD
Tramadol—Thrombocytopenia—Simvastatin—atherosclerosis	0.00033	0.00091	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000329	0.000905	CcSEcCtD
Tramadol—Insomnia—Lovastatin—atherosclerosis	0.000326	0.000899	CcSEcCtD
Tramadol—Cough—Pravastatin—atherosclerosis	0.000326	0.000898	CcSEcCtD
Tramadol—Paraesthesia—Lovastatin—atherosclerosis	0.000324	0.000892	CcSEcCtD
Tramadol—Myalgia—Niacin—atherosclerosis	0.000323	0.00089	CcSEcCtD
Tramadol—Arthralgia—Niacin—atherosclerosis	0.000323	0.00089	CcSEcCtD
Tramadol—Hypertension—Pravastatin—atherosclerosis	0.000323	0.000889	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000322	0.000888	CcSEcCtD
Tramadol—Anorexia—Simvastatin—atherosclerosis	0.000322	0.000886	CcSEcCtD
Tramadol—Dyspnoea—Lovastatin—atherosclerosis	0.000322	0.000886	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000321	0.000884	CcSEcCtD
Tramadol—Insomnia—Ezetimibe—atherosclerosis	0.00032	0.000881	CcSEcCtD
Tramadol—Chest pain—Pravastatin—atherosclerosis	0.000318	0.000876	CcSEcCtD
Tramadol—Myalgia—Pravastatin—atherosclerosis	0.000318	0.000876	CcSEcCtD
Tramadol—Arthralgia—Pravastatin—atherosclerosis	0.000318	0.000876	CcSEcCtD
Tramadol—Paraesthesia—Ezetimibe—atherosclerosis	0.000318	0.000875	CcSEcCtD
Tramadol—Dyspepsia—Lovastatin—atherosclerosis	0.000318	0.000874	CcSEcCtD
Tramadol—Anxiety—Pravastatin—atherosclerosis	0.000317	0.000873	CcSEcCtD
Tramadol—Dry mouth—Niacin—atherosclerosis	0.000316	0.00087	CcSEcCtD
Tramadol—Dyspnoea—Ezetimibe—atherosclerosis	0.000316	0.000869	CcSEcCtD
Tramadol—Discomfort—Pravastatin—atherosclerosis	0.000315	0.000866	CcSEcCtD
Tramadol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000314	0.000864	CcSEcCtD
Tramadol—Decreased appetite—Lovastatin—atherosclerosis	0.000314	0.000864	CcSEcCtD
Tramadol—Dyspepsia—Ezetimibe—atherosclerosis	0.000312	0.000858	CcSEcCtD
Tramadol—Fatigue—Lovastatin—atherosclerosis	0.000311	0.000856	CcSEcCtD
Tramadol—Anaphylactic shock—Niacin—atherosclerosis	0.00031	0.000853	CcSEcCtD
Tramadol—Pain—Lovastatin—atherosclerosis	0.000309	0.00085	CcSEcCtD
Tramadol—Constipation—Lovastatin—atherosclerosis	0.000309	0.00085	CcSEcCtD
Tramadol—Confusional state—Pravastatin—atherosclerosis	0.000308	0.000847	CcSEcCtD
Tramadol—Decreased appetite—Ezetimibe—atherosclerosis	0.000308	0.000847	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000308	0.000847	CcSEcCtD
Tramadol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000306	0.000841	CcSEcCtD
Tramadol—Asthenia—Rosuvastatin—atherosclerosis	0.000306	0.000841	CcSEcCtD
Tramadol—Insomnia—Simvastatin—atherosclerosis	0.000305	0.00084	CcSEcCtD
Tramadol—Anaphylactic shock—Pravastatin—atherosclerosis	0.000305	0.00084	CcSEcCtD
Tramadol—Fatigue—Ezetimibe—atherosclerosis	0.000305	0.00084	CcSEcCtD
Tramadol—Shock—Niacin—atherosclerosis	0.000305	0.000839	CcSEcCtD
Tramadol—Infection—Pravastatin—atherosclerosis	0.000303	0.000835	CcSEcCtD
Tramadol—Paraesthesia—Simvastatin—atherosclerosis	0.000303	0.000834	CcSEcCtD
Tramadol—Constipation—Ezetimibe—atherosclerosis	0.000303	0.000833	CcSEcCtD
Tramadol—Pain—Ezetimibe—atherosclerosis	0.000303	0.000833	CcSEcCtD
Tramadol—Tachycardia—Niacin—atherosclerosis	0.000302	0.000833	CcSEcCtD
Tramadol—Pruritus—Rosuvastatin—atherosclerosis	0.000301	0.000829	CcSEcCtD
Tramadol—Skin disorder—Niacin—atherosclerosis	0.000301	0.000829	CcSEcCtD
Tramadol—Dyspnoea—Simvastatin—atherosclerosis	0.000301	0.000828	CcSEcCtD
Tramadol—Hyperhidrosis—Niacin—atherosclerosis	0.0003	0.000825	CcSEcCtD
Tramadol—Thrombocytopenia—Pravastatin—atherosclerosis	0.000299	0.000823	CcSEcCtD
Tramadol—Feeling abnormal—Lovastatin—atherosclerosis	0.000297	0.000819	CcSEcCtD
Tramadol—Dyspepsia—Simvastatin—atherosclerosis	0.000297	0.000818	CcSEcCtD
Tramadol—Anorexia—Niacin—atherosclerosis	0.000295	0.000813	CcSEcCtD
Tramadol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000295	0.000812	CcSEcCtD
Tramadol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000295	0.000812	CcSEcCtD
Tramadol—Decreased appetite—Simvastatin—atherosclerosis	0.000293	0.000808	CcSEcCtD
Tramadol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000292	0.000803	CcSEcCtD
Tramadol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000291	0.000802	CcSEcCtD
Tramadol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000291	0.000802	CcSEcCtD
Tramadol—Fatigue—Simvastatin—atherosclerosis	0.000291	0.000801	CcSEcCtD
Tramadol—Anorexia—Pravastatin—atherosclerosis	0.000291	0.000801	CcSEcCtD
Tramadol—Hypotension—Niacin—atherosclerosis	0.00029	0.000797	CcSEcCtD
Tramadol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000289	0.000797	CcSEcCtD
Tramadol—Pain—Simvastatin—atherosclerosis	0.000289	0.000795	CcSEcCtD
Tramadol—Constipation—Simvastatin—atherosclerosis	0.000289	0.000795	CcSEcCtD
Tramadol—Urticaria—Lovastatin—atherosclerosis	0.000287	0.000789	CcSEcCtD
Tramadol—Abdominal pain—Lovastatin—atherosclerosis	0.000285	0.000785	CcSEcCtD
Tramadol—Body temperature increased—Lovastatin—atherosclerosis	0.000285	0.000785	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000282	0.000777	CcSEcCtD
Tramadol—Dizziness—Rosuvastatin—atherosclerosis	0.000282	0.000775	CcSEcCtD
Tramadol—Urticaria—Ezetimibe—atherosclerosis	0.000281	0.000774	CcSEcCtD
Tramadol—Insomnia—Niacin—atherosclerosis	0.00028	0.000772	CcSEcCtD
Tramadol—Abdominal pain—Ezetimibe—atherosclerosis	0.00028	0.00077	CcSEcCtD
Tramadol—Body temperature increased—Ezetimibe—atherosclerosis	0.00028	0.00077	CcSEcCtD
Tramadol—Paraesthesia—Niacin—atherosclerosis	0.000278	0.000766	CcSEcCtD
Tramadol—Feeling abnormal—Simvastatin—atherosclerosis	0.000278	0.000766	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000278	0.000765	CcSEcCtD
Tramadol—Dyspnoea—Niacin—atherosclerosis	0.000276	0.000761	CcSEcCtD
Tramadol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000276	0.00076	CcSEcCtD
Tramadol—Insomnia—Pravastatin—atherosclerosis	0.000276	0.00076	CcSEcCtD
Tramadol—Somnolence—Niacin—atherosclerosis	0.000276	0.000759	CcSEcCtD
Tramadol—Paraesthesia—Pravastatin—atherosclerosis	0.000274	0.000754	CcSEcCtD
Tramadol—Dyspepsia—Niacin—atherosclerosis	0.000273	0.000751	CcSEcCtD
Tramadol—Dyspnoea—Pravastatin—atherosclerosis	0.000272	0.000749	CcSEcCtD
Tramadol—Decreased appetite—Niacin—atherosclerosis	0.000269	0.000742	CcSEcCtD
Tramadol—Dyspepsia—Pravastatin—atherosclerosis	0.000269	0.000739	CcSEcCtD
Tramadol—Rash—Rosuvastatin—atherosclerosis	0.000268	0.000739	CcSEcCtD
Tramadol—Dermatitis—Rosuvastatin—atherosclerosis	0.000268	0.000738	CcSEcCtD
Tramadol—Urticaria—Simvastatin—atherosclerosis	0.000268	0.000738	CcSEcCtD
Tramadol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000268	0.000737	CcSEcCtD
Tramadol—Abdominal pain—Simvastatin—atherosclerosis	0.000267	0.000735	CcSEcCtD
Tramadol—Body temperature increased—Simvastatin—atherosclerosis	0.000267	0.000735	CcSEcCtD
Tramadol—Headache—Rosuvastatin—atherosclerosis	0.000267	0.000734	CcSEcCtD
Tramadol—Hypersensitivity—Lovastatin—atherosclerosis	0.000266	0.000732	CcSEcCtD
Tramadol—Decreased appetite—Pravastatin—atherosclerosis	0.000265	0.00073	CcSEcCtD
Tramadol—Pain—Niacin—atherosclerosis	0.000265	0.00073	CcSEcCtD
Tramadol—Fatigue—Pravastatin—atherosclerosis	0.000263	0.000724	CcSEcCtD
Tramadol—Constipation—Pravastatin—atherosclerosis	0.000261	0.000718	CcSEcCtD
Tramadol—Pain—Pravastatin—atherosclerosis	0.000261	0.000718	CcSEcCtD
Tramadol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000261	0.000718	CcSEcCtD
Tramadol—Asthenia—Lovastatin—atherosclerosis	0.000259	0.000713	CcSEcCtD
Tramadol—Pruritus—Lovastatin—atherosclerosis	0.000255	0.000703	CcSEcCtD
Tramadol—Asthenia—Ezetimibe—atherosclerosis	0.000254	0.000699	CcSEcCtD
Tramadol—Gastrointestinal pain—Niacin—atherosclerosis	0.000253	0.000698	CcSEcCtD
Tramadol—Nausea—Rosuvastatin—atherosclerosis	0.000253	0.000696	CcSEcCtD
Tramadol—Feeling abnormal—Pravastatin—atherosclerosis	0.000251	0.000692	CcSEcCtD
Tramadol—Pruritus—Ezetimibe—atherosclerosis	0.00025	0.000689	CcSEcCtD
Tramadol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00025	0.000687	CcSEcCtD
Tramadol—Hypersensitivity—Simvastatin—atherosclerosis	0.000249	0.000685	CcSEcCtD
Tramadol—Diarrhoea—Lovastatin—atherosclerosis	0.000247	0.00068	CcSEcCtD
Tramadol—Urticaria—Niacin—atherosclerosis	0.000246	0.000678	CcSEcCtD
Tramadol—Abdominal pain—Niacin—atherosclerosis	0.000245	0.000674	CcSEcCtD
Tramadol—Body temperature increased—Niacin—atherosclerosis	0.000245	0.000674	CcSEcCtD
Tramadol—Urticaria—Pravastatin—atherosclerosis	0.000242	0.000667	CcSEcCtD
Tramadol—Asthenia—Simvastatin—atherosclerosis	0.000242	0.000667	CcSEcCtD
Tramadol—Diarrhoea—Ezetimibe—atherosclerosis	0.000242	0.000667	CcSEcCtD
Tramadol—Body temperature increased—Pravastatin—atherosclerosis	0.000241	0.000664	CcSEcCtD
Tramadol—Abdominal pain—Pravastatin—atherosclerosis	0.000241	0.000664	CcSEcCtD
Tramadol—Pruritus—Simvastatin—atherosclerosis	0.000239	0.000657	CcSEcCtD
Tramadol—Dizziness—Lovastatin—atherosclerosis	0.000239	0.000657	CcSEcCtD
Tramadol—Dizziness—Ezetimibe—atherosclerosis	0.000234	0.000644	CcSEcCtD
Tramadol—Diarrhoea—Simvastatin—atherosclerosis	0.000231	0.000636	CcSEcCtD
Tramadol—Vomiting—Lovastatin—atherosclerosis	0.000229	0.000632	CcSEcCtD
Tramadol—Hypersensitivity—Niacin—atherosclerosis	0.000228	0.000629	CcSEcCtD
Tramadol—Rash—Lovastatin—atherosclerosis	0.000228	0.000626	CcSEcCtD
Tramadol—Dermatitis—Lovastatin—atherosclerosis	0.000227	0.000626	CcSEcCtD
Tramadol—Headache—Lovastatin—atherosclerosis	0.000226	0.000622	CcSEcCtD
Tramadol—Vomiting—Ezetimibe—atherosclerosis	0.000225	0.00062	CcSEcCtD
Tramadol—Hypersensitivity—Pravastatin—atherosclerosis	0.000225	0.000619	CcSEcCtD
Tramadol—Dizziness—Simvastatin—atherosclerosis	0.000223	0.000614	CcSEcCtD
Tramadol—Rash—Ezetimibe—atherosclerosis	0.000223	0.000614	CcSEcCtD
Tramadol—Dermatitis—Ezetimibe—atherosclerosis	0.000223	0.000614	CcSEcCtD
Tramadol—Asthenia—Niacin—atherosclerosis	0.000222	0.000612	CcSEcCtD
Tramadol—Headache—Ezetimibe—atherosclerosis	0.000222	0.00061	CcSEcCtD
Tramadol—Pruritus—Niacin—atherosclerosis	0.000219	0.000604	CcSEcCtD
Tramadol—Asthenia—Pravastatin—atherosclerosis	0.000219	0.000603	CcSEcCtD
Tramadol—Pruritus—Pravastatin—atherosclerosis	0.000216	0.000594	CcSEcCtD
Tramadol—Vomiting—Simvastatin—atherosclerosis	0.000215	0.000591	CcSEcCtD
Tramadol—Nausea—Lovastatin—atherosclerosis	0.000214	0.00059	CcSEcCtD
Tramadol—Rash—Simvastatin—atherosclerosis	0.000213	0.000586	CcSEcCtD
Tramadol—Dermatitis—Simvastatin—atherosclerosis	0.000213	0.000585	CcSEcCtD
Tramadol—Diarrhoea—Niacin—atherosclerosis	0.000212	0.000584	CcSEcCtD
Tramadol—Headache—Simvastatin—atherosclerosis	0.000211	0.000582	CcSEcCtD
Tramadol—Nausea—Ezetimibe—atherosclerosis	0.00021	0.000579	CcSEcCtD
Tramadol—Diarrhoea—Pravastatin—atherosclerosis	0.000209	0.000575	CcSEcCtD
Tramadol—Dizziness—Niacin—atherosclerosis	0.000205	0.000564	CcSEcCtD
Tramadol—Dizziness—Pravastatin—atherosclerosis	0.000202	0.000556	CcSEcCtD
Tramadol—Nausea—Simvastatin—atherosclerosis	0.0002	0.000552	CcSEcCtD
Tramadol—Vomiting—Niacin—atherosclerosis	0.000197	0.000542	CcSEcCtD
Tramadol—Rash—Niacin—atherosclerosis	0.000195	0.000538	CcSEcCtD
Tramadol—Dermatitis—Niacin—atherosclerosis	0.000195	0.000537	CcSEcCtD
Tramadol—Headache—Niacin—atherosclerosis	0.000194	0.000535	CcSEcCtD
Tramadol—Vomiting—Pravastatin—atherosclerosis	0.000194	0.000534	CcSEcCtD
Tramadol—Rash—Pravastatin—atherosclerosis	0.000192	0.00053	CcSEcCtD
Tramadol—Dermatitis—Pravastatin—atherosclerosis	0.000192	0.000529	CcSEcCtD
Tramadol—Headache—Pravastatin—atherosclerosis	0.000191	0.000526	CcSEcCtD
Tramadol—Nausea—Niacin—atherosclerosis	0.000184	0.000507	CcSEcCtD
Tramadol—Nausea—Pravastatin—atherosclerosis	0.000181	0.000499	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—MMP3—atherosclerosis	1.92e-05	0.000151	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF2—atherosclerosis	1.91e-05	0.00015	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOB—atherosclerosis	1.91e-05	0.00015	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KNG1—atherosclerosis	1.86e-05	0.000146	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTM1—atherosclerosis	1.86e-05	0.000146	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOB—atherosclerosis	1.85e-05	0.000145	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	1.85e-05	0.000145	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	1.84e-05	0.000145	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL8—atherosclerosis	1.84e-05	0.000144	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.83e-05	0.000144	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EDN1—atherosclerosis	1.82e-05	0.000143	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LCAT—atherosclerosis	1.82e-05	0.000143	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—FABP4—atherosclerosis	1.82e-05	0.000143	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—LPL—atherosclerosis	1.82e-05	0.000143	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	1.82e-05	0.000143	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL5—atherosclerosis	1.81e-05	0.000142	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.8e-05	0.000142	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PLG—atherosclerosis	1.8e-05	0.000142	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.8e-05	0.000141	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOA4—atherosclerosis	1.79e-05	0.00014	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—LIPC—atherosclerosis	1.78e-05	0.00014	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GPX1—atherosclerosis	1.78e-05	0.00014	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOC3—atherosclerosis	1.77e-05	0.000139	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—LPL—atherosclerosis	1.77e-05	0.000139	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	1.77e-05	0.000139	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—LDLR—atherosclerosis	1.76e-05	0.000138	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.76e-05	0.000138	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.76e-05	0.000138	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOS3—atherosclerosis	1.75e-05	0.000137	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—INS—atherosclerosis	1.75e-05	0.000137	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CD36—atherosclerosis	1.73e-05	0.000136	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.73e-05	0.000136	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.73e-05	0.000136	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CETP—atherosclerosis	1.72e-05	0.000135	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	1.72e-05	0.000135	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCL2—atherosclerosis	1.72e-05	0.000135	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.71e-05	0.000135	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.71e-05	0.000134	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	1.71e-05	0.000134	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.71e-05	0.000134	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IGF1—atherosclerosis	1.69e-05	0.000133	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SPP1—atherosclerosis	1.68e-05	0.000132	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	1.67e-05	0.000131	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP3—atherosclerosis	1.65e-05	0.00013	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.65e-05	0.000129	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.65e-05	0.000129	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF2—atherosclerosis	1.64e-05	0.000129	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOB—atherosclerosis	1.64e-05	0.000129	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTHFR—atherosclerosis	1.64e-05	0.000129	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—F2—atherosclerosis	1.63e-05	0.000128	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.62e-05	0.000128	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARA—atherosclerosis	1.61e-05	0.000126	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	1.6e-05	0.000126	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTM1—atherosclerosis	1.6e-05	0.000125	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOB—atherosclerosis	1.59e-05	0.000125	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	1.58e-05	0.000124	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EDN1—atherosclerosis	1.57e-05	0.000123	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—LPL—atherosclerosis	1.57e-05	0.000123	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.56e-05	0.000122	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AGT—atherosclerosis	1.56e-05	0.000122	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL5—atherosclerosis	1.56e-05	0.000122	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.56e-05	0.000122	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	1.55e-05	0.000122	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	1.55e-05	0.000122	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOA2—atherosclerosis	1.54e-05	0.000121	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.54e-05	0.000121	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.54e-05	0.000121	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.54e-05	0.000121	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOS3—atherosclerosis	1.53e-05	0.00012	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GPX1—atherosclerosis	1.53e-05	0.00012	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOE—atherosclerosis	1.53e-05	0.00012	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LPL—atherosclerosis	1.52e-05	0.00012	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.52e-05	0.000119	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AGT—atherosclerosis	1.51e-05	0.000119	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CAV1—atherosclerosis	1.51e-05	0.000119	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOA1—atherosclerosis	1.51e-05	0.000119	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	1.5e-05	0.000117	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.49e-05	0.000117	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CD36—atherosclerosis	1.49e-05	0.000117	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOE—atherosclerosis	1.48e-05	0.000116	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—LEP—atherosclerosis	1.48e-05	0.000116	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	1.48e-05	0.000116	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—INS—atherosclerosis	1.47e-05	0.000116	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—atherosclerosis	1.47e-05	0.000116	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CAV1—atherosclerosis	1.47e-05	0.000115	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LPA—atherosclerosis	1.47e-05	0.000115	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOA1—atherosclerosis	1.47e-05	0.000115	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL2—atherosclerosis	1.45e-05	0.000114	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SPP1—atherosclerosis	1.44e-05	0.000113	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	1.44e-05	0.000113	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1—atherosclerosis	1.43e-05	0.000112	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BGN—atherosclerosis	1.42e-05	0.000112	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ESR1—atherosclerosis	1.42e-05	0.000111	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTHFR—atherosclerosis	1.41e-05	0.000111	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOA5—atherosclerosis	1.41e-05	0.000111	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—atherosclerosis	1.4e-05	0.00011	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—F2—atherosclerosis	1.4e-05	0.00011	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.39e-05	0.000109	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	1.39e-05	0.000109	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARA—atherosclerosis	1.38e-05	0.000109	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CG—atherosclerosis	1.38e-05	0.000108	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	1.36e-05	0.000107	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	1.36e-05	0.000107	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	1.36e-05	0.000107	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.36e-05	0.000106	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	1.35e-05	0.000106	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AGT—atherosclerosis	1.34e-05	0.000105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	1.34e-05	0.000105	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	1.33e-05	0.000105	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—atherosclerosis	1.33e-05	0.000104	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOE—atherosclerosis	1.31e-05	0.000103	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	1.31e-05	0.000103	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.31e-05	0.000103	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—INS—atherosclerosis	1.3e-05	0.000102	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGT—atherosclerosis	1.3e-05	0.000102	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CAV1—atherosclerosis	1.3e-05	0.000102	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOA1—atherosclerosis	1.3e-05	0.000102	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOS3—atherosclerosis	1.29e-05	0.000102	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—atherosclerosis	1.29e-05	0.000101	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	1.28e-05	0.000101	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOE—atherosclerosis	1.28e-05	0.0001	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LEP—atherosclerosis	1.28e-05	0.0001	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—INS—atherosclerosis	1.27e-05	9.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CAV1—atherosclerosis	1.26e-05	9.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOA1—atherosclerosis	1.26e-05	9.91e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	1.26e-05	9.88e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL2—atherosclerosis	1.25e-05	9.79e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—atherosclerosis	1.24e-05	9.78e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—atherosclerosis	1.23e-05	9.64e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1—atherosclerosis	1.23e-05	9.62e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ESR1—atherosclerosis	1.22e-05	9.57e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	1.21e-05	9.54e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—F2—atherosclerosis	1.2e-05	9.45e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—atherosclerosis	1.2e-05	9.39e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	1.19e-05	9.38e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	1.19e-05	9.35e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.19e-05	9.35e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	1.19e-05	9.34e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—atherosclerosis	1.19e-05	9.31e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.17e-05	9.22e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LIPC—atherosclerosis	1.17e-05	9.16e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	1.16e-05	9.14e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOC3—atherosclerosis	1.16e-05	9.11e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	1.15e-05	9.06e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LDLR—atherosclerosis	1.15e-05	9.05e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	1.15e-05	9.05e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	1.15e-05	9.01e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—atherosclerosis	1.14e-05	8.98e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NOS3—atherosclerosis	1.14e-05	8.98e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOB—atherosclerosis	1.14e-05	8.96e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CETP—atherosclerosis	1.13e-05	8.84e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—INS—atherosclerosis	1.12e-05	8.81e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOS3—atherosclerosis	1.11e-05	8.72e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.11e-05	8.71e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.11e-05	8.71e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	1.1e-05	8.67e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	1.1e-05	8.66e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—atherosclerosis	1.09e-05	8.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—atherosclerosis	1.09e-05	8.57e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—INS—atherosclerosis	1.09e-05	8.56e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—LPL—atherosclerosis	1.09e-05	8.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.08e-05	8.47e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL2—atherosclerosis	1.07e-05	8.43e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPX1—atherosclerosis	1.06e-05	8.34e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1—atherosclerosis	1.05e-05	8.28e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—atherosclerosis	1.05e-05	8.22e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	1.04e-05	8.19e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—atherosclerosis	1.04e-05	8.15e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CD36—atherosclerosis	1.03e-05	8.13e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—atherosclerosis	1.03e-05	8.08e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	1.03e-05	8.06e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.02e-05	8e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	1.01e-05	7.95e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	1.01e-05	7.93e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	1.01e-05	7.91e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	1e-05	7.87e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	9.85e-06	7.74e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NOS3—atherosclerosis	9.84e-06	7.73e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.8e-06	7.7e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARA—atherosclerosis	9.62e-06	7.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOS3—atherosclerosis	9.56e-06	7.51e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	9.52e-06	7.48e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—atherosclerosis	9.37e-06	7.36e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	9.32e-06	7.32e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AGT—atherosclerosis	9.32e-06	7.32e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—atherosclerosis	9.23e-06	7.25e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOE—atherosclerosis	9.13e-06	7.17e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.07e-06	7.13e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CAV1—atherosclerosis	9.04e-06	7.1e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOA1—atherosclerosis	9.02e-06	7.09e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—atherosclerosis	9e-06	7.07e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—atherosclerosis	8.91e-06	7e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	8.82e-06	6.92e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	8.81e-06	6.92e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—atherosclerosis	8.7e-06	6.83e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	8.67e-06	6.81e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	8.64e-06	6.79e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	8.55e-06	6.72e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	8.48e-06	6.66e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.24e-06	6.47e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	8.19e-06	6.44e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—atherosclerosis	8.07e-06	6.34e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—atherosclerosis	8.02e-06	6.3e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	8e-06	6.28e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—atherosclerosis	7.95e-06	6.24e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—atherosclerosis	7.92e-06	6.22e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—INS—atherosclerosis	7.8e-06	6.12e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.78e-06	6.11e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—atherosclerosis	7.67e-06	6.03e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—atherosclerosis	7.63e-06	5.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	7.59e-06	5.96e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	7.57e-06	5.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	7.46e-06	5.86e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOB—atherosclerosis	7.46e-06	5.86e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	7.44e-06	5.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	7.34e-06	5.77e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.25e-06	5.7e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—atherosclerosis	7.15e-06	5.61e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LPL—atherosclerosis	7.12e-06	5.59e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—atherosclerosis	7.03e-06	5.53e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPX1—atherosclerosis	6.95e-06	5.46e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	6.89e-06	5.41e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NOS3—atherosclerosis	6.84e-06	5.37e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—atherosclerosis	6.82e-06	5.36e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CD36—atherosclerosis	6.76e-06	5.31e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	6.52e-06	5.12e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—atherosclerosis	6.44e-06	5.06e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.41e-06	5.03e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	6.32e-06	4.97e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARA—atherosclerosis	6.29e-06	4.94e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.25e-06	4.91e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AGT—atherosclerosis	6.09e-06	4.78e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOE—atherosclerosis	5.97e-06	4.69e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—atherosclerosis	5.95e-06	4.67e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CAV1—atherosclerosis	5.91e-06	4.64e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOA1—atherosclerosis	5.9e-06	4.63e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—atherosclerosis	5.53e-06	4.35e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.39e-06	4.23e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—atherosclerosis	5.26e-06	4.13e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—atherosclerosis	5.2e-06	4.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—atherosclerosis	5.11e-06	4.01e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—INS—atherosclerosis	5.1e-06	4e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—atherosclerosis	4.76e-06	3.74e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—atherosclerosis	4.67e-06	3.67e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—atherosclerosis	4.52e-06	3.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NOS3—atherosclerosis	4.47e-06	3.51e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—atherosclerosis	4.4e-06	3.45e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.09e-06	3.21e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—atherosclerosis	3.14e-06	2.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—atherosclerosis	2.06e-06	1.61e-05	CbGpPWpGaD
